MEDIPAL HOLDINGS CORPORATION
7459・Prime Market・Wholesale Trade
MEDIPAL HOLDINGS CORPORATION7459
MEDIPAL HOLDINGS CORPORATION7459
Reference Indicators
Market Cap
6,160¥100M
P/E (Forecast)
15.0x
P/B
0.9x
Dividend Yield (Forecast)
2.38%
ROE
6.7%
EV/EBITDA
4.1x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 3,290,921 | 3,360,008 | 3,558,732 | 3,671,328 | 3,817,354 |
Cost of Sales | 3,073,476 | 3,135,703 | 3,312,077 | 3,415,569 | 3,556,366 |
Gross Profit | 217,445 | 224,304 | 246,654 | 255,758 | 260,987 |
SG&A Expenses | 171,820 | 175,331 | 199,324 | 200,148 | 207,804 |
Operating Income | 45,624 | 48,972 | 47,330 | 55,609 | 53,182 |
Non-operating Income | 17,131 | 17,590 | 19,414 | 16,046 | 25,422 |
Non-operating Expenses | 710 | 1,440 | 2,174 | 6,401 | 2,881 |
Ordinary Income | 62,046 | 65,122 | 64,570 | 65,255 | 75,723 |
Extraordinary Income | 873 | 14,123 | 11,963 | 12,694 | 21,849 |
Extraordinary Losses | 5,635 | 9,184 | 1,793 | 1,215 | 15,727 |
Pre-tax Income | 57,284 | 70,061 | 74,741 | 76,734 | 81,844 |
Income Taxes | 18,087 | 21,738 | 22,973 | 25,203 | 28,703 |
Net Income | 29,423 | 38,806 | 41,474 | 40,279 | 42,534 |
EBITDA | 59,962 | 63,620 | 65,312 | 74,026 | 80,164 |
Gross Margin | 6.6% | 6.7% | 6.9% | 7.0% | 6.8% |
Operating Margin | 1.4% | 1.5% | 1.3% | 1.5% | 1.4% |
ROA | 1.7% | 2.3% | 2.3% | 2.2% | 2.2% |
ROE | 5.6% | 7.1% | 7.1% | 6.6% | 6.7% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 医療用医薬品等卸売事業 | 2,462,464 | 24,292 | 1.0% |
| 化粧品・日用品、一般用医薬品卸売事業 | 1,237,563 | 26,430 | 2.1% |
| 動物用医薬品・食品加工原材料卸売等関連事業 | 117,326 | 2,325 | 2.0% |